Adaptive Randomization in Clinical Trials

Design and Analysis of Experiments

Volumn 3, Issue , 2012, Pages 251-281

  Zhang, Lanju ^a   Rosenberger, William F ^b,c,d  

^a MEDIMMUNE   (United States)

^b George Mason University   (United States)

^c AMERICAN STATISTICAL ASSOCIATION   (United States)

^d Institute of Mathematical Statistics   (United States)

Author keywords

Adaptive randomization in trials, blocking, randomization, replication; Adaptive randomization, Response Adaptive, Covariate Adaptive, Restricted; Randomization based inference, advantages of randomization

Indexed keywords

ADAPTIVE RANDOMIZATION IN TRIALS, BLOCKING, RANDOMIZATION, REPLICATION; CLINICAL TRIAL; COVARIATES; RANDOMIZATION-BASED INFERENCE, ADVANTAGES OF RANDOMIZATION;

RANDOM PROCESSES;

EID: 84864292858     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118147634.ch7     Document Type: Chapter

References (56)

1. Atkinson, A.C. (1999). Optimum biased-coin designs for sequential treatment allocation with covariate information. Statistics in Medicine, 18, 1741-1752.
2. Bai, Z., F. Hu, and W.F. Rosenberger (2002). Asymptotic properties of adaptive designs with delayed response. Annals of Statistics, 30, 122-139.
3. Biswas, A. and S. Mandal (2004). Optimal adaptive designs in phase III clinical trials for continuous responses with covariates. In: mODa7: Advances in Model-Oriented Design and Analysis, A. Di Bucchianico, H. Lauter, and H.P. Wynn (eds.). Heidelberg, Germany: Physica-Verlag, pp. 51-58.
4. Coad, D.S. and Z. Govindarajulu (2000). Corrected confidence intervals following a sequential adaptive trial with binary response. Journal of Statistical Planning and Inference, 91, 53-64.
5. Coad, D.S. and A. Ivanova (2001). Bias calculations for adaptive urn designs. Sequential Analysis, 20, 229-239.
6. Coad, D.S. and M.B. Woodroofe (1997). Approximate confidence intervals after a sequential clinical trial comparing two exponential survival curves with censoring. Journal of Statistical Planning and Inference, 63, 79-96.
7. Cornfield, J., M. Halperin, and S.W. Greenhouse (1969). An adaptive procedure for sequential clinical trials. Journal of the American Statistical Association, 64, 759-770.
8. Cox, D.R. (1982). A remark on randomization in clinical trials. Utilitas Mathematica, 21A, 245-252.
9. Dragalin, V. (2006). Adaptive designs:Terminology and classification. DrugInformation Journal, 40, 425-435.
10. Ebbutt, A., R. Kay, J. McNamara, and J. Engler (1997). The analysis of trials using a minimisation algorithm. In: Statisticians in the Pharmaceutical Industry Annual Conference Report, 1997, PSI (ed.). London: PSI, pp. 12-15.
11. Efron, B. (1971). Forcing a sequential experiment to be balanced. Biometrika, 58, 403-417.
12. Eisele, J. (1994). The doubly adaptive biased coin design for sequential clinical trials. Journal of Statistical Planning and Inference, 38, 249-262.
13. FDA (2010). Guidance for industry: Adaptive design clinical trials for drugs and biologics. Silver Spring: U.S. Food and Drug Administration (draft guidance).
14. Fisher, R.A. (1935). The Design of Experiments. New York: Hafner Press.
15. Flyer, P.A. (1998). A comparison of conditional and unconditional randomization tests for highly stratified data. Biometrics, 54, 1551-1559.
16. Freedman, B. (1987). Equipoise and the ethics of clinical research. The New England Journal of Medicine, 317, 141-145.
17. Gail, M.H., W.Y. Tan, and S. Piantadosi (1988). Tests for no treatment effect in randomized clinical trials. Biometrika, 75, 57-64.
18. Hu, F. and W.F. Rosenberger (2003). Optimality, variability, power: Evaluating response-adaptive randomization procedures for treatment comparisons. Journal of American Statistical Association, 98, 671-678.
19. Hu, F. and W.F. Rosenberger (2006). The Theory of Response-Adaptive Randomization in Clinical Trials. New York: Wiley.
20. Hu, F. and L.-X. Zhang (2004). Asymptotic properties of doubly adaptive biased coin design for multi-treatment clinical trials. Annals of Statistics, 32, 268-301.
21. Hu, F., W.F. Rosenberger, and L.-X. Zhang (2006). Asymptotically best response-adaptive randomization procedures for treatment comparisons. Journal of Statistical Planning and Inference, 136, 1911-1922.
22. Hu, F., L.-X. Zhang, and X. He (2009). Efficient randomized adaptive designs. Annals of Statistics, 37, 2543-2560.
23. Ivanova, A. (2003). A play-the-winner type urn model with reduced variability. Metrika, 58, 1-13.
24. Jennison, C. and B.W. Turnbull (2000). Group Sequential Methods With Applications to Clinical Trials. Boca Raton, FL: Chapman and Hall/CRC.
25. Kuznetsova, O. and A. Ivanova (2007). Allocation in randomized clinical trials. In: Pharmaceutical Statistics Using SAS: A Practical Guide, A. Dmitrienko, C. Chuang-Stein, and R.B.D. Agostino (eds.). Cary, NC: SAS Institute, pp. 213-235.
26. Lehmann, E.L. (1974). Nonparametrics: Statistical Methods Based on Ranks. Oakland, CA: Holden-Day.
27. Lehmann, E.L. (1986). Testing Statistical Hypotheses. New York: Wiley.
28. Markaryan, T. and W.F. Rosenberger (2010). Exact properties of Efron's biased coin randomization procedure. Annals of Statistics, 38, 1546-1567.
29. Melfi, V.F., C. Page, and M. Geraldes (2001). An adaptive randomized design with application to estimation. The Canadian Journal of Statistics, 29, 107-116.
30. Miller, E., S. Deleger, and J. Murphy (2005). Implementing and managing adaptive designs for clinical trials. Pharma Supplies and News, October 21.
31. Miller, P.B. and C. Weijer (2006). Trust based obligations of the state and physician-researchers to patient-subjects. Journal of Medical Ethics, 32, 542-547.
32. Pesarin, F. (2001). Multivariate Permutation Tests With Applications in Biostatistics. Chichester, UK: Wiley.
33. Pocock, S.J. and R. Simon (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31, 103-115.
34. Prentice, R.J. (1978). Linear rank tests with right-censored data. Biometrika, 65, 167-179.
35. Quinlan, J.A. and M. Krams (2006). Implementing adaptive designs: Logistical and operational considerations. Drug Information Journal, 40, 437-444.
36. Rosenberger, W.F. (1993). Asymptotic inference with response-adaptive treatment allocation designs. Annals of Statistics, 21, 2098-2107.
37. Rosenberger, W.F. and F. Hu (1999). Bootstrap methods for adaptive designs. Statistics in Medicine, 18, 1757-1767.
38. Rosenberger, W.F. and F. Hu (2004). Maximizing power and minimizing treatment failures in clinical trials. Clinical Trials, 1, 141-147.
39. Rosenberger, W.F. and J.L. Lachin (2002). Randomization in Clinical Trials: Theory and Practice. New York: Wiley.
40. Rosenberger, W.F. and O. Sverdlov (2008). Handling covariates in the design of clinical trials. Statistical Science, 23, 404-419.
41. Rosenberger, W.F., N. Stallard, A. Ivanova, C. Harper, and M. Ricks (2001). Optimal adaptive designs for binary response trials. Biometrics, 57, 173-177.
42. Royall, R.M. (1991). Ethics and statistics in randomized clinical trials. Statistical Science, 6, 52-62.
43. Shao, J., X. Yu, and B. Zhong (2010). A theory for testing hypotheses under covariate-adaptive randomization. Biometrika, 97, 347-360.
44. Simon, R. (1979). Restricted randomization designs in clinical trials. Biometrics, 35, 503-512.
45. Simon, R. (1991). A decade of progress in statistical methodology for clinical trials. Statistics in Medicine, 10, 1789-1817.
46. Smith, R.L. (1984). Sequential treatment alloation using biased coin designs. Journal of the Royal Statistical Society. Series B, 46, 519-543.
47. Wei, L.J. (1978). An application of an urn model to the design of sequential controlled clinical trials. Journal of the American Statistical Association, 73, 559-563.
48. Wei, L.J. and S. Durham (1978). The randomized play-the-winner rule in medical trials. Journal of the American Statistical Association, 73, 840-843.
49. Weinstein, M.C. (1974). Allocation of subjects in medical experiments. New England Journal of Medicine, 291, 1278-1285.
50. Wendler, D. (2009). The ethics of clinical research. In: Stanford Encyclopedia of Philosophy, E.N. Zalta (ed.). Stanford, CA: Stanford University.
51. Yuan, A. and G.X. Chai (2008). Optimal adaptive generalized Polya urn design for multi-arm clinical trials. Journal of Multivariate Analysis, 99, 1-24.
52. Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic Disease, 27, 365-375.
53. Zhang, L. and W.F. Rosenberger (2006). Response-adaptive randomization for clinical trials with continuous outcomes. Biometrics, 62, 562-569.
54. Zhang, L. and W.F. Rosenberger (2007). Response-adaptive randomization for clinical trials with survival outcomes: The parametric approach. Journal of the Royal Statistical Society. Series C, 53, 153-165. Zhang, L. and W.F. Rosenberger (2011). Optimal response-adaptive randomization in clinical trials. In: Handbook of Adaptive Designs for Pharmaceutical and Clinical Development, A. Pong and S. Chow (eds.). Boca Raton, FL: CRC Press, pp. 15-1. 15-13.
55. Zhang, L. and W.F. Rosenberger (2011). Optimal response-adaptive randomization in clinical trials. In: Handbook of Adaptive Designs for Pharmaceutical and Clinical Development, A. Pong and S. Chow (eds.). Boca Raton, FL: CRC Press, pp. 15-21. 15-23.
56. Zhang, L.-X., W.S. Chan, S.H. Cheung, and F. Hu (2007). A generalized urn model for clinical trials with delayed responses. Statistica Sinica, 17, 387-409.